Tenet Healthcare (NYSE:THC) Director Nadja West Sells 3,000 Shares

Tenet Healthcare Corporation (NYSE:THC) Director Nadja West sold 3,000 shares of the company’s stock in a transaction dated Wednesday, May 27th. The stock was sold at an average price of $177.35, for a total value of $532,050.00. Following the transaction, the director directly owned 24,805 shares of the company’s stock, valued at $4,399,166.75. This represents a 10.79% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.

Tenet Healthcare Stock Down 4.2%

THC traded down $7.61 on Thursday, hitting $173.45. 1,121,464 shares of the company were exchanged, compared to its average volume of 1,578,558. Tenet Healthcare Corporation has a 12 month low of $146.60 and a 12 month high of $247.21. The company has a market cap of $14.94 billion, a PE ratio of 9.02, a PEG ratio of 1.19 and a beta of 1.30. The company has a debt-to-equity ratio of 1.96, a quick ratio of 1.30 and a current ratio of 1.36. The stock’s fifty day moving average is $190.50 and its 200-day moving average is $202.06.

Tenet Healthcare (NYSE:THC) last released its earnings results on Thursday, April 30th. The company reported $4.82 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.21 by $0.61. Tenet Healthcare had a return on equity of 25.55% and a net margin of 7.94%.The business had revenue of $5.37 billion for the quarter, compared to analyst estimates of $5.39 billion. During the same quarter in the prior year, the company posted $4.36 earnings per share. Tenet Healthcare’s revenue was up 2.6% on a year-over-year basis. Tenet Healthcare has set its FY 2026 guidance at 16.380-18.68 EPS. Equities research analysts predict that Tenet Healthcare Corporation will post 17.67 EPS for the current fiscal year.

Analysts Set New Price Targets

Several research firms recently issued reports on THC. Leerink Partners upped their target price on Tenet Healthcare from $255.00 to $264.00 and gave the stock an “outperform” rating in a report on Friday, February 20th. UBS Group upped their price objective on Tenet Healthcare from $260.00 to $288.00 and gave the company a “buy” rating in a research note on Thursday, February 12th. Cantor Fitzgerald restated an “overweight” rating on shares of Tenet Healthcare in a research note on Wednesday, March 4th. Truist Financial upped their price objective on Tenet Healthcare from $240.00 to $270.00 and gave the company a “buy” rating in a research note on Tuesday, February 17th. Finally, Wall Street Zen lowered Tenet Healthcare from a “strong-buy” rating to a “buy” rating in a research note on Monday, May 11th. Nineteen equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $244.16.

Hedge Funds Weigh In On Tenet Healthcare

Several institutional investors and hedge funds have recently made changes to their positions in the company. WCM Investment Management LLC grew its position in Tenet Healthcare by 244.4% during the third quarter. WCM Investment Management LLC now owns 510,224 shares of the company’s stock worth $102,657,000 after buying an additional 362,083 shares in the last quarter. AlphaQuest LLC grew its position in Tenet Healthcare by 238.3% during the third quarter. AlphaQuest LLC now owns 5,965 shares of the company’s stock worth $1,211,000 after buying an additional 4,202 shares in the last quarter. Winnow Wealth LLC acquired a new stake in shares of Tenet Healthcare during the 3rd quarter worth $1,129,000. Savant Capital LLC grew its holdings in shares of Tenet Healthcare by 27.5% during the 3rd quarter. Savant Capital LLC now owns 16,894 shares of the company’s stock worth $3,430,000 after purchasing an additional 3,647 shares in the last quarter. Finally, Caption Management LLC acquired a new position in Tenet Healthcare in the third quarter valued at about $5,650,000. Institutional investors and hedge funds own 95.44% of the company’s stock.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.